AP BIOSCIENCES INC has a total of 28 patent applications. It increased the IP activity by 800.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, Australia and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are POMONA RICERCA SRL, IGM BIOSCIENCES INC and ENGMAB SARL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 4 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Singapore | 2 | |
#9 | Taiwan | 2 | |
#10 | WIPO (World Intellectual Property Organization) | 2 | |
#11 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Her Jeng-Horng | 22 |
#2 | Hsu Ching-Hsuan | 18 |
#3 | Huang Po-Lin | 17 |
#4 | You Jhong-Jhe | 17 |
#5 | Hsieh Hsin-Ta | 7 |
#6 | Chang Ting-Yi | 7 |
#7 | Kan Hung-Tsai | 7 |
#8 | Chen Huang-Tsu | 7 |
#9 | Huang Po Lin | 2 |
#10 | Her Jeng Horng | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020263879A1 | Antibodies for t-cell activation | |
WO2019168947A1 | Bifunctional proteins combining checkpoint blockade for targeted therapy | |
AU2018394939A1 | Monospecific and bispecific proteins with immune checkpoint regulation for cancer therapy |